INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION

25th Regional Congress of the ISBT

 

June 27- July 1, 2015 London
Close
N. Poster
Poster title
Applicant name
Status
  2-P STEPWISE QUALITY IMPROVEMENT IN A SMALL SCALE CARIBBEAN BLOOD BANK LONG TERM SUCCESS OF PROCESS APPROACH Willem Smid Received Received
  11-P RISK-BASED DECISION-MAKING FOR BLOOD SAFETY Connor Hubbard-MacLeod Received Received
  17-P THE USE OF CELLULAR AND TABLET DEVICES AS A TEACHING AND INFORMATION RESOURCE TOOL Jerry Squires Received Received
  18-P STANDARDIZED 2D LABEL DESIGN FOR BLOOD PRODUCTS Ruth Miller Received Received
  30-P BLOOD UTILIZATION IN ELECTIVE SURGERY IN A TERTIARY CENTER IN LAGOS, NIGERIA sarah john-olabode Received Received
  33-P BLENDED LEARNING MODEL FOR REGULATED TRAINING IN A BLOOD CENTER Paula Howard Received Received
  60-P PATIENT BLOOD MANAGEMENT ORGANISATION AND ACTIVITIES IN SEVEN EUROPEAN UNIVERSITY HOSPITALS Kate Pendry Received Received
  62-P WHERE DID THE BLOOD GO?BLOOD USE AT THE UNIVERSITY HOSPITAL OF COLOGNE Laura Behrens Received Received
  76-P LARGE SUSTAINED REDUCTION IN THE TRANSFUSION OF FRESH FROZEN PLASMA AFTER ESTABLISHMENT OF A CULTURE CHANGE Joseph Sweeney Received Received
  85-P IMPROVING (AND MEASURING) BLOOD TRACEABILITY, PRODUCTION PROCESS CONTROL AND EFFICIENCY WITH RFID-BASED SOLUTION RHESUS AT SEVILLES REGIONAL TRANSFUSION CENTRE Juan Pedro Benitez Received Received
  96-P TRANSFUSION KEY PERFORMANCE INDICATORS - ONE YEARS EXPERIENCE Julie Johnson Received Received
  102-P CHALLENGES IN CHANGE CONTROL IN BLOOD ESTABLISHMENTS (BE) - HOW AND WHEN CORRECTLY CHANGE LOCATION OF BLOOD SEPARATORS IN USE AND VALIDATE NEW SEPARATORS AT THE SAME TIME Zoran Bolta Received Received
  113-P GENETIC FACTORS ASSOCIATED WITH FERRITIN LEVELS: A STUDY IN THE AUSTRALIAN DONOR POPULATION Helen Faddy Received Received
  115-P WHY ARE YOU NOT DONATING FOR VNRBD? A DESCRIPTION OF REASONS Tanya Christiansen Received Received
  128-P DONOR EXPECTATIONS AND COUNSELLING IN KUMASI, GHANA Veena Sharma Received Received
  132-P VOLUNTARY AND DIRECTED BLOOD DONORS PROBLEMS AND ATTITUDE SONIA SHORMIN MIAH Received Received
  137-P GIVE BLOOD FOR THE FIRST TIME AND FOREVER. THE NEW PROMOTION CAMPAIGN BY AVIS, THE ITALIAN VOLUNTEER BLOOD DONORS ASSOCIATION Boris Zuccon Received Received
  147-P DISTANCE TO THE BLOOD BANK MATTERS Tanya Christiansen Received Received
  162-P WHEN WOULD YOU PREFER TO DONATE BLOOD? Tanya Christiansen Received Received
  167-P A PROSPECTIVE ANALYSIS OF THE PRODUCTIVITY OF MCS UPP-999 (HAEMONETICS) AND AMICUS 3.21 (FRESENIUS KABI) IN 222 APHERESIS DONORS Angel Luis Pajares Herraiz Received Received
  168-P POST DONATION INFORMATION: IS IT USEFUL, IS IT TIMELY? Susan Barnes Received Received
  169-P EFFECTS OF OPTIA RED CELL EXCHANGE TRANSFUSION IN SICKLE CELL DISEASE ON BLOOD PARAMETERS ASSOCIATED WITH BLEEDING RISK Gavin Cho Received Received
  175-P INFLUENCE OF APHERESIS INLET BLOOD FLOW ON THE QUALITY PRODUCT OF HAEMATOPOIETIC PROGENITOR STEM CELLS COLLECTION EVA ALONSO Received Received
  177-P PLATELETAPHERESIS IN NIGERIA: THE UNIVERSITY OF BENIN TEACHING HOSPITAL, BENIN CITY EXPERIENCE Benedict Nwogoh Received Received
  198-P PREVENTION OF FAINTING REACTIONS AFTER WHOLE BLOOD DONATION: A CLUSTER RANDOMIZED TRIAL TO ASSESS THE EFFICACY OF HYDRATION WITH ISOTONIC SOLUTION, WATER AND APPLIED MUSCLE TENSION Chrystelle Morand Received Received
  223-P EFFECTS OF SUPER-COOLING BY MEANS OF MAGNETISM ON CRYOPRESERVATION OF BLOOD PRODUCTS IN VITRO Geir Hetland Received Received
  231-P EVALUATION OF THE TPL IMUFLEX CRC SET INCLUDING THE NEW SEPACELLTM R-S01 LEUKOREDUCTION FILTER FOR RED BLOOD CELL UNITS Melanie Stoermer Received Received
  232-P HEMOLYSIS IN IN-DATE RED CELL CONCENTRATES Joseph Sweeney Received Received
  238-P STATUS OF ADDITIVE SOLUTION 7 John Hess Received Received
  242-P THE UK NATIONAL FROZEN BLOOD BANK : A FIVE YEAR REVIEW OF PROVISION OF RARE PHENOTYPED UNITS Gina MacLaren Received Received
  259-P RATE OF PLATELET BACTERIAL CONTAMINATION IN UGANDA Aaron Tobian Received Received
  267-P THROMBOLUX EVALUATION OF PLATELET QUALITY AND BACTERIAL CONTAMINATION IN BUFFY COAT PLATELET CONCENTRATES Annette Vetlesen Received Received
  272-P PREPARATION OF THAWED WASHED RED CELLS SUITABLE FOR INTRA-UTERINE (IUT) AND NEONATAL TOP-UP TRANSFUSION Gina MacLaren Received Received
  283-P PREPARATION OF POOLED PLATELETS IN ADDITIVE SOLUTION Zharas Bibekov Received Received
  287-P IDENTIFYING MAJOR DONOR AND PROCESS PARAMETERS ON FVIII AND FIBRINOGEN CONTENT OF FFP24 Stéphane Bégué Received Received
  294-P THE ASSESSMENT OF PLATELET FUNCTION BY THROMBELASTOGRAPHY AFTER TRANSFUSION OF INTERCEPT TREATED PLATELETS REVEALS SATISFYING RESULTS. Gerda Leitner Received Received
  300-P CHIKUNGUNYA AND ROSS RIVER VIRUSES ARE EFFECTIVELY INACTIVATED BY THE THERAFLEX UV-PLATELETS TECHNOLOGY Denese Marks Received Received
  302-P PARVOVIRUS B19 TRANSMISSION BY TRANSFUSION OF INTERCEPT BLOOD SYSTEM-TREATED THROMBOCYTE CONCENTRATE Christoph Niederhauser Received Received
  310-P RFID TAGS ROBUSTNESS AND TRACEABILITY IN THE PROCESS OF METHYLENE BLUE TREATED PLASMA Nicolas de Valensart Received Received
  315-P REDUCTION OF FEBRILE AND ALLERGIC REACTIONS IN PATIENTS RECEIVING PLATELETS TREATED WITH RIBOFLAVIN AND UV LIGHT Teresa Jimenez-Marco Received Received
  322-P VALIDATION OF DOUBLE DOSE BUFFY-COAT PLATELET PROCESSING USING THE INTERCEPT DUAL STORAGE PROCESSING SET PREPARED FROM SEVEN BUFFY-COATS Angel Luis Pajares Herraiz Received Received
  325-P STABILITY AND INTER-DONOR VARIABILITY OF SERUM GROWTH FACTORS STORED IN DIFFERENT SERUM EYE DROP PACKAGING SYSTEMS Denese Marks Received Received
  328-P LYSATES PRODUCED FROM IRRADIATED AND EXPIRED BUFFY COAT-DERIVED PLATELETS STORED IN ADDITIVE SOLUTION SUPPORT CELL PROLIFERATION Yen Siew Loh Received Received
  329-P DYNAMIC LIGHT SCATTERING AS A TOOL FOR THE ANALYSIS OF PLATELET QUALITY FOLLOWING CRYOPRESERVATION Lacey Johnson Received Received
  336-P COMPARISON OF THE PREVALENCE OF INFECTIOUS AGENTS IN ENGLISH BLOOD AND DECEASED TISSUE DONORS Kitchen Alan Received Received
  337-P THIRTEEN YEARS OF NAT SCREENING IN BLOOD DONORS: NEW INSIGHTS ON HIV, HCV AND HBV INCIDENT CASES, THE FRENCH EXPERIENCE Syria LAPERCHE Received Received
  340-P THE IMPORTANCE OF CONFIRMATORY TESTING OF DONATIONS THAT ARE REACTIVE ON INFECTIOUS DISEASE SCREENING Ania Zuczkowska Received Received
  342-P HOW DO WE RESPOND TO NEW KNOWLEDGE CONCERNING HEV RNA PREVALENCE IN GERMAN BLOOD DONOR BASE AND THE RISK OF TRANSMISSION TO IMMUNCOMPROMISED RECIPIENTS? ? HEV NAT-TESTING FOR THROMBAPHERESIS AND SDR DONATIONS Christine Scheuch Received Received
  346-P PERFORMANCE CHARACTERISTICS OF A TRANSCRIPTION-MEDIATED AMPLIFICATION ASSAY FOR PARVOVIRUS B19 AND HEPATITIS A VIRUS ON A FULLY AUTOMATED SYSTEM Edgar Ong Received Received
  354-P IMPLEMENTATION OF THE NEW COBAS 6800/COBAS P 680 AND COBAS MPX FOR NAT SCREENING OF BLOOD DONATIONS: A SAFETY AND EFFICIENCY TOOL LUISA BAREA Received Received
  356-P VALIDATION OF THE COBAS MPX TEST ON THE COBAS 8800 SYSTEM IN A ROUTINE BLOOD TRANSFUSION SCREENING LABORATORY Martin Stolz Received Received
  358-P EVALUATION OF THE PROCLEIX ULTRIO ELITE ASSAY (GRIFOLS) FOR NAT HIV-1/2, HCV AND HBV SCREENING ON BLOOD DONORS AND ON CELL AND TISSUE BANK SPECIMENS Rodenbach Marie-Pierre Received Received
  383-P COMPARISON OF DIFFERENT TECHNIQUES USED IN A TRANSFUSION TRANSMITTED INFECTION LABORATORY IN THE BLOOD BANK SUDHA Ranganathan Received Received
  392-P NUCLEIC ACID AMPLIFICATION TEST(NAT) TO DETECT HBV INFECTION IN BLOOD DONORS Surekha Devi Allanki Received Received
  394-P APPARENT DISCREPANCY BETWEEN THE VIRUS CONCENTRATIONS IN THE 2ND AND 4TH WHO INTERNATIONAL HCV STANDARDS Peter Gowland Received Received
  407-PA ANALYSIS OF HIV-1 SUBTYPES AMONG HIV-POSITIVE BLOOD DONORS IN CATALONIA (SPAIN) Marta Bes Received Received
  422-P INSIGHTS INTO BACTERIAL SURVIVAL AND DISTRIBUTION DURING BUFFY COAT PLATELET PRODUCTION Sandra Ramirez Received Received
  430-P PERFORMANCE OF A NEW AUTOMATED SYPHILIS ASSAY FOR THE DETECTION OF THE PRESENCE OF ANTIBODIES TO TREPONEMA PALLIDIUM George Schlauder Received Received
  436-P SURVEY FOR BACTERIAL TESTING IN PLATELET CONCENTRATES IN LATIN AMERICA Sandra Ramirez Received Received
  439-P MALARIA AND T.CRUZI SCREENING IN UK DECEASED ORGAN DONORS Mhairi Webster Received Received
  442-P EVALUATION OF NOVALISA MALARIA MALARIA AB ASSAY Kitchen Alan Received Received
  444-P PLATELET CONCENTRATES: HIGH-RISK BLOOD COMPONENTS IN THE TRANSFUSION- TRANSMISSION OF TRYPANOSOMA CRUZI IN NON- ENDEMIC CHAGAS DISEASE AREAS. Beatriz Cancino-Faure Received Received
  454-P PERFORMANCE CHARACTERISTICS OF A TMA ASSAY FOR DENGUE VIRUS DETECTION ON A FULLY AUTOMATED PLATFORM AND EVALUATION OF THE IMPACT OF POOLING USING BLOOD DONATIONS FROM PUERTO RICO Vanessa Bres Received Received
  455-P TRANSFUSION TRANSMITTED ANAPLASMOSIS FROM POOLED PLATELETS Joseph Sweeney Received Received
  459-P COMPARISON OF TWO COMMERCIAL HEPATITIS E VIRUS ELISA KITS IN AUSTRALIAN BLOOD DONOR SAMPLES Helen Faddy Received Received
  460-P HEPATITIS A VIRUS ANTIBODY LEVELS IN SEROPOSITIVE BLOOD DONORS Helen Faddy Received Received
  465-P CONFIRMATION OF ANTI-HTLV SCREEN REACTIVITY Kitchen Alan Received Received
  478-P TRANSFUSION SUPPORT AND MANAGEMENT FOR A PREGNANT THALASSAEMIA INTERMEDIA PATIENT WITH ANTI-Jra Nay Win Received Received
  484-P FURTHER EVIDENCE FOR THE CLINICAL SIGNIFICANCE OF ANTI-JRA MALCOLM NEEDS Received Received
  498-P INTRODUCTION OF AN ADDITIONAL RED CELL ANTIBODY SCREENING TEST AT 36 WEEKS IN PREGNANT WOMEN RECEIVING ROUTINE ANTENATAL ANTI-D (RAADP) AT 28-30 WEEKS OF PREGNANCY Kati Sulin Received Received
  499-P POTENTIAL INTERFERENCE OF DARATUMUMAB IN ROUTINE BLOOD TRANSFUSION POLICIES AND SEROLOGICAL TESTS EVA ALONSO Received Received
  524-P RECOMBINANT GROUP PROTEINS PROVED TO BE A HELPFUL TOOL FOR ANTIBODY SCREENING IN PRESENCE OF AN ANTI-KN(A) Christof Weinstock Received Received
  525-P A CASE: RHD ALLOIMMUNIZATION AFTER TRANSFUSION OF ONE UNIT OF APHERESIS PLATELETS Yanhua Li Received Received
  530-P HIGH FIDELITY ANTIBODY IMMOBILIZED MICROBEAD TECHNOLOGY FOR BLOOD TYPING kazumi kawakami Received Received
  574-P GENOTYPING TO REDUCE ANTI-D IMMUNOGLOBULIN USAGE IN A DIVERSE POPULATION DEMOGRAPHIC: FETAL RHD DETECTION FOR MOTHERS HARBOURING RHD VARIANTS Robert Flower Received Received
  578-P A PATIENT OF CAUCASIAN ORIGIN WITH AN APPARENT FY(A-B-) PHENOTYPE Christine Henny Received Received
  608-P HIGH-THROUGHPUT PERFORMANCE TESTING OF A FOCUSED BLOOD GROUP GENOTYPING PANEL IN A LARGE COHORT OF DNA SAMPLES Anders Nygren Received Received
  611-P A MISSING RHD-CE-D HYBRID IN AN RHD POSITIVE BLOOD DONOR: IMPLICATIONS FOR FUTURE BLOOD GROUP INTERPRETATIVE ALGORITHMS Robert Flower Received Received
  622-P ROUTINE COMPLEMENTARY MOLECULAR AND SEROLOGIC ANTIGEN DETERMINATION IN A EUROPEAN, MAINLY HEMATOLOGIC PATIENT POPULATION Franz Wagner Received Received
  628-P A NOVEL SSO GENOTYPING METHOD FOR BLOOD GROUP ALLELES ON MR.SPOT SYSTEM Marina Albrizio Received Received
  636-P NEW INSIGHTS INTO THE GENDER DIFFERENCES IN HEMOLYSIS: EFFECT OF TESTOSTERONE AND MAPK-MEDIATED HEMOLYSIS IN MICE Tamir Kanias Received Received
  651-P DIAGNOSTIC POTENTIAL OF MULTIPLE ASSAYS OF ANTI-HPA-1A FOR PREDICTION OF FETAL THROMBOCYTOPENIA IN HPA-1A ALLOIMMUNISED WOMEN Belinda Kumpel Received Received
  678-P SUCCESSFUL MANAGEMENT OF HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN DUE TO AN ANTI-RH17 ANTIBODY Akila CHANDRASEKAR Received Received
  686-P ASSESSING FOR IMMUNODEFICIENCY AND THE NEED FOR IRRADIATED BLOOD PRODUCTS IN CHILDREN WITH SUSPECTED DIGEORGE SYNDROME UNDERGOING CARDIAC SURGERY A UK SURVEY Sara Mele Received Received
  687-P INDICATIONS AND USE OF CRYOPRECIPITATE IN THE PEDIATRIC INTENSIVE CARE UNIT Melissa Cushing Received Received
  694-P AUDIT OF PLASMA EXCHANGE FOR HYPERVISCOSITY AT NHSBT TAS OXFORD: THE CHANGING ROLE OF THERAPEUTIC APHERESIS Elizabeth Marrinan Received Received
  697-P NHSBT NATIONAL THERAPEUTIC APHERESIS SERVICES STANDARDISED PRACTICE RESULTS IN EXCELLENT PATIENT OUTCOMES IN TTP Sylvia Benjamin Received Received
  714-P RBC ANTIGEN PHENOTYPE MATCHED RED CELL TRANSFUSIONS FOR THALASSEMIA PATIENTS TO PREVENT ALLOIMMUNSATION : HOW MUCH IS ENOUGH? PRITI ELHENCE Received Received
  715-P POST-TRANSFUSION HYPERHAEMOLYSIS SYNDROME (PTHS) IN SICKLE CELL DISEASE (SCD): AN AUTOPSY FINDINGS SUPPORTING MACROPHAGE ACTIVATION Nay Win Received Received
  716-P PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA IN SOUTH-EAST NORWAY 2000-2010 HISTORY, DIAGNOSTICS AND TREATMENT Lise Sofie H. Nissen-Meyer Received Received
  719-P USE OF MANUAL AND ELECTRONIC INFUSION DEVICES TO RED BLOOD CELLS TRANSFUSION: SEEKING EVIDENCES FOR NURSING PRACTICE Mavilde Pedreira Received Received
  724-P SUCCESS OF PBM IN JAPAN SUPPORTED BY FEES FOR SERVICE Shoichi Inaba Received Received
  727-P FOUR YEARS OF TAILORED LOW DOSE PROPHYLAXIS IN A SMALL COHORT OF KIDS WITH SEVERE HEMOPHILIA A USING SD-F CRYOPRECIPITATE Ahmed El Ekiaby Received Received
  730-P THE DEVELOPMENT OF A BIG TRANSFUSION DATASET IN A LARGE TEACHING HOSPITAL Kate Pendry Received Received
  758-P MANAGEMENT OF WARFARIN-ASSOCIATED COAGULOPATHY (WAC) IN PATIENTS WITH ACUTE GASTROINTESTINAL BLEEDING (GIB) Jaroslava Andreeva Received Received
  768-P NOTIFY LIBRARY OF ADVERSE OUTCOMES FROM MEDICAL PRODUCTS OF HUMAN ORIGIN EXPANDS TO INCLUDE BLOOD Barbee Whitaker Received Received
  772-P TRALI: ASSOCIATED WITH DONOR PRIMARY AUTOIMMUNE NEUTROPENIA Nuala Moore Received Received
  782-P SHOULD WE TRANSFUSE AT NIGHT? Rebecca Patel Received Received
  786-P IGA DEFICIENCY AND TRANSFUSION REACTIONS: A CASE REPORT ILLUSTRATING CURRENT PATIENT MANAGEMENT Kathryn Musgrave Received Received
  790-P VALIDATION OF A TRANSFUSION SAFETY SYSTEM BASED ON RFID TECHNOLOGY Anna Millan Received Received
  792-P HAEMOVIGIL: A NOVEL SYSTEM TO PREVENT BEDSIDE PHLEBOTOMY AND TRANSFUSION ERRORS DUE TO PATIENT MIS-IDENTIFICATION Gautam Wankhede Received Received
  804-P PATIENT CHARACTERISTICS AND RATE OF ACUTE TRANSFUSION REACTIONS TO PLATELET TRANSFUSIONS IN UGANDA Aaron Tobian Received Received
  820-P QUALITY OF CRYOPRESERVED CORD BLOOD UNITS IN THE PUBLIC CORD BLOOD BANK OF KOREA Hye Ryun Lee Received Received
  827-P FLOW CYTOMETRY ANNEXIN V AND 7AAD FOR ASSESSMENT OF GRAFT QUALITY IN ALLOGENEIC HSC TRANSPLANTATION Emma Watz Received Received
  834-P IMPACT OF ABO-BLOOD GROUP INCOMPATIBILITY ON TRANSFUSION OUTCOME AND SURVIVAL OF PATIENTS UNDERGOING SINGLE-UNIT UMBILICAL CORD BLOOD TRANSPLANTATION: EXPERIENCE OF A SINGLE INSTITUTION Pilar Solves Received Received
  837-P ALLELIC TYPING OF KIR2DL1 AND KIR3DL1 GENES TO DEFINE LOW/HIGH AFFINITY RECEPTOR-LIGAND COMBINATIONS AND IMPROVE DONOR SELECTION IN STEM CELL TRANSPLANTATION Christian Seidl Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
07:45
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

25th Regional Congress of the ISBT

 

June 27- July 1, 2015 London
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 01/07/2015 TO 01/07/2016
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.2015isbt.2015 




PosterSessionOnline
Logo Draft
 
Logo Cert